Murdoch Childrens Research Institute
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 1986-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.mcri.edu.au
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Phase 4
Not yet recruiting
- Conditions
- AllergyImmunotherapyVenom Allergy
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06935890
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Royal Hobart Hospital, Hobart, Tasmania, Australia
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation
Phase 1
Not yet recruiting
- Conditions
- Scabies
- Interventions
- Drug: ivermectin infant formula preparationDrug: Standard ivermectin 3mg tablet
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 52
- Registration Number
- NCT06918665
- Locations
- 🇦🇺
The Royal Children's Hospital, Melbourne, Victoria, Australia
Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Not Applicable
Not yet recruiting
- Conditions
- Unmet Fertility Information Needs
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 358
- Registration Number
- NCT06894810
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial
Not Applicable
Not yet recruiting
- Conditions
- Allergy
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 194
- Registration Number
- NCT06686446
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Using Artificial Intelligence to Screen for Hip Dysplasia
Not Applicable
Recruiting
- Conditions
- Developmental Dysplasia of Hip
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 240
- Registration Number
- NCT06647225
- Locations
- 🇦🇺
Royal Children's Hospital, Parkville, Victoria, Australia
Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
Phase 2
Recruiting
- Conditions
- Cytomegalovirus Viraemia
- Interventions
- Drug: Standard dosing of IV ganciclovirDrug: Personalised dosing of IV ganciclovir
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 232
- Registration Number
- NCT06574789
- Locations
- 🇦🇺
Sydney Children's Hospital, Sydney, New South Wales, Australia
🇦🇺The Royal Children's Hospital, Melbourne, Victoria, Australia
🇦🇺The Children's Hospital at Westmead, Sydney, New South Wales, Australia
Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.
Phase 2
Recruiting
- Conditions
- Solid Organ Transplant
- Interventions
- Diagnostic Test: Genotyping for CYP3A4 and CYP3A5 genesDevice: Use of NextDose platform
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 45
- Registration Number
- NCT06529536
- Locations
- 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia
A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Phase 1
Not yet recruiting
- Conditions
- Hodgkin LymphomaNon Hodgkin Lymphoma
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 10
- Registration Number
- NCT06383338
- Locations
- 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy
Phase 2
Withdrawn
- Conditions
- Peanut Allergy
- Interventions
- Dietary Supplement: Probiotic (LGG®, Lactobacillus Rhamnosus) or placebo probiotic (maltodextrin)
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Murdoch Childrens Research Institute
- Registration Number
- NCT06297083
The Egg Up Trial - Testing a New Treatment Pathway for Infants with Newly Diagnosed Egg Allergy
Not Applicable
Active, not recruiting
- Conditions
- Food Allergy in InfantsFood Allergy
- Interventions
- Other: Egg Ladder
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 109
- Registration Number
- NCT06273605
- Locations
- 🇦🇺
Murdoch Children's Research Institute (MCRI), Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath